Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
19.54
+0.23 (1.19%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Sabra Health Care REIT stock have an average target of 21.34, with a low estimate of 18.73 and a high estimate of 25. The average target predicts an increase of 9.21% from the current stock price of 19.54.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sabra Health Care REIT stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 8 | 8 | 8 | 7 | 7 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 13 | 13 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Seth Bergey Citi No rating | Citi | Hold Downgrades $24 → $19 | Hold | Downgrades | $24 → $19 | -2.76% | Jun 22, 2026 |
| Scotiabank | Scotiabank | Hold Maintains $22 → $19 | Hold | Maintains | $22 → $19 | -2.76% | Jun 18, 2026 |
| Raymond James | Raymond James | Sell Initiates $19 | Sell | Initiates | $19 | -4.15% | Jun 16, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $25 | Buy | Maintains | $25 | +27.94% | Jun 10, 2026 |
| UBS | UBS | Hold Reiterates $21 → $22 | Hold | Reiterates | $21 → $22 | +12.59% | May 13, 2026 |
Financial Forecast
Revenue This Year
888.69M
from 775.76M
Increased by 14.56%
Revenue Next Year
983.71M
from 888.69M
Increased by 10.69%
EPS This Year
0.67
EPS Next Year
0.74
from 0.67
Increased by 10.94%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 944.0M | 1.1B | |
| Avg | 888.7M | 983.7M | |
| Low | 800.4M | 842.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.7% | 25.5% | |
| Avg | 14.6% | 10.7% | |
| Low | 3.2% | -5.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.67 | 0.77 | |
| Avg | 0.67 | 0.74 | |
| Low | 0.67 | 0.71 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.1% | 14.9% | |
| Avg | 11.1% | 10.9% | |
| Low | 11.1% | 6.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.